NPPA computed the Retail Price of Vildagliptin IP 100mg (as sustained release form) + Metformin Hydrochloride (as sustained release form) IP 1000mg

Oct 07, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on October 03, 2024, issued the Computation of Retail Price of Vildagliptin IP 100mg (as sustained release form) + Metformin Hydrochloride (as sustained release form) IP 1000mg.

The following has been stated namely: -

• The Retail Price has been computed based on the data from February, 2024

• The Retail Price has been computed for Each Film Coated Tablet Containing Vildagliptin IP 100mg (as sustained release form) + Metformin Hydrochloride (as sustained release form) IP 1000mg for M/s Pure and Cure Healthcare Pvt Ltd. (manufacturer) and M/s Primus Remedies Pvt Ltd.

• The Total MAT is 1,01,53,100

[Notification No. 19(4196)/2024/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT